glp-1 drugs covered by medicare What to know about covering GLP-1
Description
Major challenges in TDDS include limited drug-loading capacity and inadequate skin penetration, due to the low mechanical strength of polymeric microneedles or variations in skin properties between individuals
doi: 10.1038/s41366-025-01859-6
Heres where GLP-1 drugs start getting interesting
Yoon KH, Kang J, Kwon SC, et al
Clinically diagnosed gastroparesis in GLP-1 users appears uncommon, though precise incidence rates are difficult to establish
Ironically, those with diagnosed Type 2 diabetes appear to do worse
